Abstract
Venous thromboembolism (VTE) is an important cause of perioperative morbidity and mortality in patients with cancer [1,2]. Thromboprophylaxis initiated in the postoperative period and continued until hospital discharge can reduce the risk of symptomatic VTE by up to 70% [3,4]. However, the risk of VTE may be sustained beyond hospitalization especially in patients undergoing cancer-related surgeries [5]. Hence, current clinical practice guidelines recommend extended duration of thromboprophylaxis for up to 4 weeks after cancer-related major abdominal or pelvic surgery [6–8].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
